These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 31363465)
1. Biomarkers Balaceanu LA World J Clin Cases; 2019 Jun; 7(12):1367-1382. PubMed ID: 31363465 [TBL] [Abstract][Full Text] [Related]
2. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial. An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190 [TBL] [Abstract][Full Text] [Related]
3. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875 [TBL] [Abstract][Full Text] [Related]
4. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol. Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. Jiang HY; Chen J; Xia CC; Cao LK; Duan T; Song B World J Gastroenterol; 2018 Jun; 24(22):2348-2362. PubMed ID: 29904242 [TBL] [Abstract][Full Text] [Related]
6. Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers. Ayoub WS; Steggerda J; Yang JD; Kuo A; Sundaram V; Lu SC Ther Adv Med Oncol; 2019; 11():1758835919869120. PubMed ID: 31523283 [TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review. Singal AG; Lim JK; Kanwal F Gastroenterology; 2019 Jun; 156(8):2149-2157. PubMed ID: 30878469 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939 [TBL] [Abstract][Full Text] [Related]
10. Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines. Kim TH; Yoon JH; Lee JM Korean J Radiol; 2019 Jun; 20(6):863-879. PubMed ID: 31132813 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435 [TBL] [Abstract][Full Text] [Related]
12. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection. Matsui S; Ichida T; Watanabe M; Sugitani S; Suda T; Takahashi T; Asakura H J Gastroenterol Hepatol; 2000 Oct; 15(10):1205-11. PubMed ID: 11106103 [TBL] [Abstract][Full Text] [Related]
13. Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma. Shindo K; Maekawa S; Komatsu N; Tatsumi A; Miura M; Sato M; Suzuki Y; Matsuda S; Muraoka M; Amemiya F; Fukasawa M; Yamaguchi T; Nakayama Y; Uetake T; Inoue T; Sakamoto M; Sato T; Enomoto N Mediators Inflamm; 2015; 2015():687484. PubMed ID: 26494948 [TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances. Navin PJ; Venkatesh SK J Clin Transl Hepatol; 2019 Mar; 7(1):72-85. PubMed ID: 30944823 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers for virus-induced hepatocellular carcinoma (HCC). Mathew S; Ali A; Abdel-Hafiz H; Fatima K; Suhail M; Archunan G; Begum N; Jahangir S; Ilyas M; Chaudhary AG; Al Qahtani M; Mohamad Bazarah S; Qadri I Infect Genet Evol; 2014 Aug; 26():327-39. PubMed ID: 24956436 [TBL] [Abstract][Full Text] [Related]
16. Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma. Hennedige T; Venkatesh SK World J Gastroenterol; 2016 Jan; 22(1):205-20. PubMed ID: 26755871 [TBL] [Abstract][Full Text] [Related]
18. CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma. Jang HJ; Kim TK; Burns PN; Wilson SR Eur J Radiol; 2015 Sep; 84(9):1623-35. PubMed ID: 26092406 [TBL] [Abstract][Full Text] [Related]
19. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009 [TBL] [Abstract][Full Text] [Related]
20. Management of small hepatocellular carcinoma. Leoni S; Piscaglia F; Righini R; Bolondi L Acta Gastroenterol Belg; 2006; 69(2):230-5. PubMed ID: 16929622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]